Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|68|4-6|391-397

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 391-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequency of Febrile Neutropenia in Breast Cancer Patients Receiving Epirubicin and Docetaxel/Paclitaxel with Colony-Stimulating Growth Factors: A Comparison of Filgrastim or Lenograstim with Pegfilgrastim

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 290-293

Karger

Access to resources Recommend Favorite

Combination of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support for the Treatment of Refractory or Relapsed Small-Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen

By  

Oncology Research and Treatment, Vol. 25, Iss. 4, 2002-09 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 504-511

Karger

Access to resources Recommend Favorite

Capecitabine and docetaxel combination for the treatment of breast cancer

By Morishita Mariko   Leonard Robert C  

Women's Health, Vol. 4, Iss. 1, 2008-01 ,pp. : 11-22

Future Medicine

Access to resources Recommend Favorite